India, June 29 -- The Government of India has issued a release:
The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has invited applications from eligible entities under the Scheme for Strengthening of Medical Device Industry (SMDI) to promote domestic manufacturing, reduce import dependence, support innovation and increase the depth of value chains in the medical devices sector.
Applications are invited under the following two sub-schemes:
Selected applicants would be incentivised through one-time capital subsidy of up to Rs.10 crore on reimbursement basis for manufacturing key components/ raw material/ finished devices/ accessories to reduce import dependence under Marginal Investment Scheme.
The department will provide financial support of up to Rs.5 crore under MDCSS Scheme for conducting clinical investigation/clinical performance evaluation/Post Market Follow-up Study/animal studies to the eligible applicants on reimbursement basis.:
Proposals under the Scheme have to be submitted through the online portal http://smdi.lsssdc.in on or before 23 July 2026 (6:00 PM). For details regarding eligibility, application procedure and other terms and conditions, please visit the Department of Pharmaceuticals website at https://pharma-dept.gov.in/schemes.
Disclaimer: Curated by HT Syndication.
